Stéphane Bancel, Moderna CEO (Christopher Goodney/Bloomberg via Getty Images)
Updated: Moderna partners with Blackstone on flu shots, nabbing up to $750M in R&D funding
Moderna announced Wednesday that it is teaming up with Blackstone for its influenza program.
Under the collaboration, Blackstone will provide “up to $750 million,” according …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.